Cognitive Care for Older Adults with Type 2 Diabetes

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)

Recruiting N/A Interventional Study
Diabetes Diabetes Mellitus Type 2 Type 2 Diabetes Type 2 Diabetes Mellitus (T2DM) Cognitive Impairment Cognitive Decline
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
420 (estimated)
Sponsor
Steno Diabetes Center Copenhagen · Other
Who this trial is looking for

This trial is looking for older adults with type 2 diabetes who want to help understand and improve brain health. Participants will undergo cognitive tests and may receive interventions aimed at preventing cognitive decline.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 65 years old
  • I have been diagnosed with type 2 diabetes
  • I visit an outpatient clinic at Bispebjerg Hospital, Rigshospitalet, or Steno Diabetes Center Copenhagen
  • I speak and understand Danish
  • I can provide informed written consent

You may not be able to join if

  • I have been diagnosed with dementia
  • I have been referred to a dementia clinic
  • I have a psychiatric or neurological disorder that affects my participation
  • I am unwilling to engage in parts of the intervention

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of The Brain Care Study is to investigate the prevalence of cognitive impairment in older adults with type 2 diabetes (T2D) and to evaluate the effectiveness of a multidomain intervention designed to prevent cognitive decline.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for the Prevalence Study (Cognitive Screening): * Age ≥ 65 years * Diagnosis of Type 2 Diabetes (T2D) * Patient at the outpatient clinic at either Bispebjerg Hospital, Rigshospitalet, or Steno Diabetes Center Copenhagen * Speaks and understands Danish (required for the cognitive …
Contacts

Malin S. D. Nilsson, MD, PhD

+4550595861

malin.nilsson@regionh.dk

CONTACT